Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Gains from Investment Securities (2016 - 2026)

Myriad Genetics has reported Gains from Investment Securities over the past 17 years, most recently at -$700000.0 for Q4 2025.

  • Quarterly Gains from Investment Securities fell 105.3% to -$700000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.0 million through Dec 2025, down 114.93% year-over-year, with the annual reading at -$2.0 million for FY2025, 114.93% down from the prior year.
  • Gains from Investment Securities was -$700000.0 for Q4 2025 at Myriad Genetics, up from -$1.5 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $13.2 million in Q4 2024 and troughed at -$1.5 million in Q3 2025.
  • The 5-year median for Gains from Investment Securities is $200000.0 (2022), against an average of $1.5 million.
  • Year-over-year, Gains from Investment Securities soared 164.71% in 2021 and then tumbled 366.67% in 2023.
  • A 5-year view of Gains from Investment Securities shows it stood at $900000.0 in 2021, then crashed by 133.33% to -$300000.0 in 2022, then skyrocketed by 3000.0% to $8.7 million in 2023, then skyrocketed by 51.72% to $13.2 million in 2024, then plummeted by 105.3% to -$700000.0 in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Gains from Investment Securities are -$700000.0 (Q4 2025), -$1.5 million (Q3 2025), and $100000.0 (Q2 2025).